Merge Healthcare claimed that the new CIMS solution is the first open platform in the industry that allows organisations involved in clinical trials to transparently execute the imaging portion of the study within the overall electronic trial management solution.
etrials CIMS is the first commercially available 21 CFR Part 11 compliant network for managing all aspects of imaging in clinical trials.
The CIMS platform automates the full workflow of image submission, image storage in a vendor-neutral DICOM archive, and image analysis and viewers. This allows radiology experts, sponsors, sites, and CROs to more efficiently and economically complete the imaging portion of a clinical trial.
Merge Healthcare claimed that CIMS can fully integrate with any EDC system to provide end-to-end visibility to all data in a clinical trial. Merge Healthcare is planning to introduce CIMS solution at the DIA Annual Meeting held in Washington, DC from June 13-16, 2010.
Justin Dearborn, CEO of Merge Healthcare, said: “Currently radiologists who participate in clinical trials have to move from reading images on fast and robust PACS solutions for normal work, to reading trial images on totally different applications or even film. It is terribly inefficient for them, and the FedEx costs of moving film are very expensive for the trial sponsors.
“We developed the new CIMS solution specifically to truly solve these workflow issues. We believe it will save time and money by providing a better reading environment, and it should really change the way imaging in clinical trials is done across the industry.
“Our entry into the eClinical space last year was predicated on a strategic objective to combine our core expertise in imaging with EDC technology. The launch of the CIMS solution is the realization of this, and we are looking forward to introducing our customers and partners to this new solution, as well as myEDC and the entire eClinical suite, at the DIA.”